The rest is here: MacroGenics Announces MGD019 Publication in Cell Reports Medicine
The rest is here: MacroGenics Announces MGD019 Publication in Cell Reports Medicine
Continued here: Transactions in connection with share buyback program
See more here: Valneva Shareholders Approve EGM Resolutions to Support Potential US IPO Plan
Read the original post: VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
View post: Advaxis Announces Listing Transfer to Nasdaq Capital Market and Additional 180-day Extension by Nasdaq to Regain Compliance with Minimum Bid Price...
Link: Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease
Visit link: Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
Read the rest here: GENFIT: Renegotiation of the OCEANEs Convertible Bond Terms: Availability of Prospectus Relating to the Admission of New Shares Following Conversion...
More here: CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
Read more: Quotient Limited Announces Departure of Chief Operating Officer
Recent Comments